This content is machine translated Medical oncology A multidisciplinary approach to an innovative future The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates and healthcare professionals from around the world. Once again this year, the latest ground-breaking data was…
View Post 8 min This content is machine translated Urology Bladder cancer and co. – the latest findings from research The EAU’s annual conference is the largest urological event with thousands of healthcare professionals. In a four-day program, lectures, case discussions and debates were presented as well as live surgeries.…
View Post 4 min This content is machine translated Urooncology From diagnosis to therapy: Urological tumors in focus Annually, the American Society of Clinical Oncology Congress addresses the current state of research on urogenital tumors. The latest study results regarding diagnosis and therapy of prostate cancer, renal cell…
View Post 4 min This content is machine translated Prostate cancer and co. The most important congress information at a glance Europe’s largest urology event, the 38th EAU Annual Congress, included live surgeries, cutting-edge lectures, case discussions and debates during the four-day scientific exchange. To emphasize the multidisciplinary nature of urology,…
View Post 4 min This content is machine translated Metastatic urothelial carcinoma of the urinary bladder Therapy in transition Despite the pandemic, this year’s Swiss Oncology and Hematology Congress (SOHC) was held face-to-face – with more than 1300 participants. Metastatic urothelial carcinoma of the urinary bladder was also a…
View Post 10 min This content is machine translated Advanced urothelial carcinoma of the urinary bladder Systemic therapy With approximately 1150 new cases annually in Switzerland, urothelial carcinoma of the urinary bladder is one of the most common cancers of older age. Particularly in the metastatic setting, it… CME-Test
View Post 7 min This content is machine translated Urothelial carcinoma The role of checkpoint inhibitors Immunotherapy is also becoming increasingly important in the treatment of urothelial carcinoma. Checkpoint inhibitors are already being used successfully, particularly in advanced tumors. Now, potential applications of avelumab, atezolizumab and…
View Post 8 min This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
View Post 2 min This content is machine translated Bladder Cancer Immunotherapy after chemo may prolong survival Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
View Post 1 min This content is machine translated Cancer as an occupational disease What occupational activities increase the risk of bladder cancer? Carcinogens that enter the body through respiration or with food are filtered out by the kidneys into the urine and temporarily stored in the bladder. There, the carcinogens can act…
View Post 2 min This content is machine translated Bladder Cancer Promising immunotherapy A new phase I trial with a compound targeting the immunosuppressive protein PDL1 shows promising results with a good toxicity profile. This provides a potentially new class of drugs for…
